
Mechanism: ARA-290 protects against hyperglycemia-induced neural damage, promotes nerve regeneration, and improves microvascular circulation to peripheral nerves.
Can ARA 290 treat neuropathy?
The small peptide ARA290, modeled from the 3-dimensional structure of EPO, has shown efficacy in preclinical models of disease, including neuropathy, without associated adverse effects.
Can Ara 290 treat diabetes?
ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes.
FOR RESEARCH USE ONLY